Application no. and date | 10747168.2 (espacenet) (Federated) (European Patent Register), 20100812 | Patent/reg. no. and date | DK/EP 2464382, 20170503 | Publication date | 20120620 | Priority no. and date | EP 09010489, 20090814 | EP pub. no. and date |
EP 2464382 20120620 | Effective date | | Applicant/owner | Roche Glycart AG, Wagistrasse 18
8952 Schlieren-Zuerich, CH | Applicant ref. no. | 61950DK01 | Inventor | HERTING, Frank, An der Freiheit 29a
82377 Penzberg, DE, KLEIN, Christian, Chapfstrasse 26B
8906 Bonstetten, CH | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | Opponent | | IPC Class | A61K 31/4184 (2006.01) , A61K 39/395 (2006.01) , A61P 35/00 (2006.01) , C07K 16/28 (2006.01) | Title | KOMBINATIONSTERAPI AF ET AFUCOSYLERET CD20-ANTISTOF OG BENDAMUSTIN | Int. application no. | EP2010004939 | Int. publication no. | WO2011018224 | Related patent (certificate) | CA 2017 00050 | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|